| |
| |
|
| Insider
Information: |
Aunins John G. |
| Relationship: |
Chief Technology Offic... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
105,250 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$78,874 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
105,250 |
|
|
| Total
Value |
$78,874 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Seres Therapeutics, Inc. |
MCRB |
Chief Technology Offic... |
2020-01-26 |
105,250 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MCRB |
Seres Therapeutics, Inc. |
Chief Technology Officer & EVP |
• – – |
2020-01-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
105,250 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
Chief Technology Officer |
• – – |
2019-01-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
92,750 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
Chief Technology Officer & EVP |
• – – |
2018-12-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
85,250 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
Chief Technology Officer & EVP |
• – – |
2018-12-17 |
4 |
AS |
$6.39 |
$91,313 |
D/D |
(14,282) |
75,250 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
See Remarks |
• – – |
2018-11-15 |
4 |
AS |
$8.26 |
$117,912 |
D/D |
(14,279) |
89,532 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
See Remarks |
• – – |
2018-10-15 |
4 |
AS |
$5.94 |
$84,800 |
D/D |
(14,279) |
103,811 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
See Remarks |
• – – |
2018-09-17 |
4 |
AS |
$7.27 |
$103,875 |
D/D |
(14,279) |
118,090 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
See Remarks |
• – – |
2018-08-15 |
4 |
AS |
$7.57 |
$108,069 |
D/D |
(14,279) |
132,369 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
Chief Technology Officer & EVP |
• – – |
2018-07-15 |
4 |
AS |
$8.10 |
$115,726 |
D/D |
(14,279) |
160,927 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
Chief Technology Officer & EVP |
• – – |
2018-06-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
175,206 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
Chief Technology Officer & EVP |
• – – |
2018-06-15 |
4 |
AS |
$8.57 |
$122,325 |
D/D |
(14,279) |
170,206 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
See Remarks |
• – – |
2018-05-15 |
4 |
AS |
$8.08 |
$115,400 |
D/D |
(14,279) |
146,648 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
Chief Technology Officer & EVP |
• – – |
2018-04-25 |
4 |
AS |
$7.58 |
$108,266 |
D/D |
(14,279) |
184,485 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
See Remarks |
• – – |
2018-01-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
200,502 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
See Remarks |
• – – |
2018-01-26 |
4 |
S |
$11.02 |
$19,153 |
D/D |
(1,738) |
198,764 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
See Remarks |
• – – |
2017-12-19 |
4/A |
S |
$10.14 |
$16,457 |
D/D |
(1,623) |
195,502 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
See Remarks |
• – – |
2017-12-19 |
4/A |
OE |
$0.00 |
$0 |
D/D |
5,000 |
197,125 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
Chief Technology Officer & EVP |
• – – |
2017-12-19 |
4 |
S |
$10.14 |
$16,457 |
D/D |
(1,623) |
59,437 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
Chief Technology Officer & EVP |
• – – |
2017-12-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
61,060 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
Chief Technology Officer & EVP |
• – – |
2016-08-29 |
4 |
AS |
$10.87 |
$102,069 |
D/D |
(9,390) |
192,125 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
Chief Technology Officer & EVP |
• – – |
2016-07-27 |
4 |
AS |
$35.00 |
$323,750 |
D/D |
(9,250) |
201,515 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
Chief Technology Officer & EVP |
• – – |
2016-07-25 |
4 |
AS |
$34.18 |
$320,950 |
D/D |
(9,390) |
210,765 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
Chief Technology Officer & EVP |
• – – |
2016-07-22 |
4 |
OE |
$0.48 |
$90,000 |
D/D |
187,500 |
220,155 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
Chief Technology Officer & EVP |
• – – |
2016-06-27 |
4 |
AS |
$27.23 |
$255,690 |
D/D |
(9,390) |
32,655 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
Chief Technology Officer & EVP |
• – – |
2016-05-31 |
4 |
AS |
$30.02 |
$421,088 |
D/D |
(14,015) |
42,045 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
